最强的蛋白质结合剂是令人惊的不稳定
Alba Fernandez-Calvo1, Antonio Reifs1, Laura Saa2
1Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain.
Protein science : a publication of the Protein Society
|June 12, 2024
概括
细菌粘合物如凝聚因子A (ClfA) 强烈地结合宿主蛋白. 然而,这项研究揭示了ClfA.
科学领域:
- 微生物学 微生物学
- 生物物理学的生物物理.
- 分子生物学分子生物学
背景情况:
- 细菌粘附蛋白介导宿主细胞的附着,从而引发感染.
- 识别粘合性矩阵分子 (MSCRAMMs) 的微生物表面成分,如金黄色葡萄球菌ClfA,结合宿主蛋白质,如纤维原素 (Fg).
- MSCRAMMs表现出捕捉键行为,承受高力,但粘合剂本身的内在强度尚不清楚.
研究的目的:
- 为了研究黄金葡萄球菌粘合物的内在机械强度,凝结因子A (ClfA).
- 为了确定观察到的ClfA-Fg相互作用的高机械强度是否来自单独的ClfA或相互作用.
主要方法:
- 单分子力光谱法用于测量键断裂力.
- 生物物理结合试验用于量化相互作用强度.
- 分子模拟以建模蛋白质行为和相互作用.
主要成果:
- ClfA-Fg相互作用可以承受超过2nN的力,模仿共价键.
- 尽管有强烈的相互作用,但单独ClfA并不具有特殊的内在机械强度.
- 机械稳定性归因于特定的ClfA-Fg相互作用,而不是ClfA固有的特性.
结论:
- 结合ClfA-Fg的显著机械强度是相互作用的特征,而不仅仅是粘合物.
- 了解这些贡献对于开发抗细菌感染的抗粘附策略至关重要.
- 这项研究提供了细菌粘附和宿主-病原体相互作用的生物物理学的见解.
相关概念视频
02:18The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
01:29Drug Distribution: Plasma Protein Binding
5.5K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.5K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
96
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
96
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
150
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
150
02:40Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
01:16Protein-Drug Binding: Mechanism and Kinetics
416
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
416